Drug maker Granules India on Friday said it has received approval from the US health regulator to market a generic medication to treat major depressive disorder. The company has received approval from ...

What we're seeing is that this drug has a fairly benign safety profile.” Supernus is aiming to share data from the phase 2b trial, which is testing SPN-820 in treatment-resistant depression (TRD ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder. Granules said it has now a total of 67 ANDA approvals from the ...

As Wes Streeting suggests new weight-loss jabs could be given to unemployed people to help them get back into work, doctors ...

I know that SSRIs can be a real mixed bag; I'm one of the lucky one-third who has never achieved "remission." Taking an SSRI ...

The Flandreau Indian School Student and Parent handbook explicitly states, "Failure to take prescribed medication is a Health ...

Sep. 6, 2024 — Serotonin in depression is highly relevant in diagnosis, treatment, and drug development. To better study this area, a team has now developed a fluorescent probe for imaging ...

Dear PDSA, my dog sadly passed away recently, and I’m left with quite a few packets of tablets of the various medications he was on. Can I donate these to an animal charity? Nelson Dear Nelson ...

Former President  Rodrigo Duterte will not be called yet to the Senate when it starts its investigation into the bloody drugs ...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment ... laid out its plans to develop the drug known as COMP360, which is a ...

Read the Medication Guide provided by your pharmacist ... This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.